Health Care & Life Sciences » Pharmaceuticals | International Isotopes Inc.

International Isotopes Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
456.40
558.50
398.00
314.50
796.80
828
Total Accounts Receivable
1,046.40
783.90
1,084.90
774.30
635.00
820.40
Inventories
1,478.30
1,049.10
1,111.60
1,476.20
1,951.50
2,765.70
Other Current Assets
613.80
351.00
543.10
736.40
344.60
315
Total Current Assets
3,594.90
2,742.60
3,137.60
3,301.50
3,728.00
4,729.20
Net Property, Plant & Equipment
2,271.20
2,214.90
1,932.30
1,948.10
1,935.50
1,906.20
Total Investments and Advances
1,573.00
1,593.50
1,885.60
1,943.40
453.60
622.40
Intangible Assets
4,478.70
4,399.20
4,287.80
4,186.30
5,888.20
5,732.30
Other Assets
90.20
-
-
-
-
-
Total Assets
12,008.00
10,950.10
11,243.20
11,379.30
12,005.30
12,990.10
ST Debt & Current Portion LT Debt
341.40
1,262.90
45.90
3,392.10
67.40
Accounts Payable
732.40
635.90
1,044.00
941.70
1,619.20
Other Current Liabilities
610.80
702.90
1,396.30
3,177.00
3,827.60
Total Current Liabilities
1,684.60
2,601.70
2,486.20
7,510.80
5,514.30
Long-Term Debt
4,910.70
3,922.70
4,072.40
1,278.90
4,976.70
Provision for Risks & Charges
-
450.60
459.70
469.00
478.40
Other Liabilities
566.40
-
642.10
364.40
689.00
Total Liabilities
7,161.60
6,975.00
7,660.30
9,623.10
11,658.40
Common Equity (Total)
4,777.90
3,900.80
3,516.30
1,706.00
1,230.30
Total Shareholders' Equity
4,777.90
3,900.80
3,516.30
1,706.00
1,230.30
Total Equity
4,846.40
3,975.20
3,582.90
1,756.10
346.90
Liabilities & Shareholders' Equity
12,008.00
10,950.10
11,243.20
11,379.30
12,005.30
Accumulated Minority Interest
68.50
74.40
66.60
50.20
1,577.20

About International Isotopes

View Profile
Address
4137 Commerce Circle
Idaho Falls Idaho 83401
United States
Employees -
Website http://www.intisoid.com
Updated 07/08/2019
International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt teletherapy sources, as well as radioisotopes and radiochemicals for medical research and clinical devices. It operates through the following segments: Radiochemical Products, Cobalt Products, Nuclear Medicine Products, Radiological Services, Fluorine Products, and Transportation. The Radiochemical Products segment includes production and distribution of various isotopically pure radiochemicals for medical, industrial, or research applications.